Clinical Trial Update: SHR-1701 With or Without Apatinib in Combination With Chemotherapy as Neoadjuvant Therapy for Gastric Cancer [Phase 2]

View source ↗

Summary

This is a Phase 2 clinical trial evaluating SHR-1701 with or without apatinib plus chemotherapy as neoadjuvant therapy for gastric adenocarcinoma; the study sta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Adenocarcinoma

Drugs mentioned

• Apatinib (apatinib)
• SHR-1701

Snippet

Sponsor: The First Affiliated Hospital with Nanjing Medical University | Conditions: Gastric Adenocarcinoma | Phase 2 | Status: NOT_YET_RECRUITING